Prenzler, Anne; Yen, Linnette; Mittendorf, Thomas; Schulenburg, Johann-Matthias Graf von der
(London : BioMed Central Ltd., 2011)
Background: The treatment of ulcerative colitis (UC) can place a substantial financial burden on healthcare systems. The anti-inflammatory compound 5-aminosalicylic acid (5-ASA; mesalazine) is the recommended first-line ...